PMDAがAPECの優良研修センターとして正式に承認 ｜報道発表資料｜厚生労働省
https://www.mhlw.go.jp/stf/houdou/0000153615.htmlThe evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.
PMDAがAPECの優良研修センターとして正式に承認 ｜報道発表資料｜厚生労働省
Open the archived HTML with saved-time metadata attached.
This HTML has CSS and images embedded, so it can still be opened even if the original page disappears.
This page announces that PMDA was formally approved as an APEC Center of Excellence for Regulatory Science in March 2017. PMDA was recognized in two fields: international joint clinical trials/GCP inspections and pharmaceutical safety monitoring. PMDA, Duke-NUS Medical School (Singapore), and Peking University (China) were approved for the international joint clinical trials field. Japan co-chairs the RHSC with the United States. PMDA will conduct training for pharmaceutical regulatory authorities in the APEC region and contribute to promoting ICH guidelines.
